BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1654789)

  • 1. Development of synthetic peptide substrates for the poliovirus 3C proteinase.
    Weidner JR; Dunn BM
    Arch Biochem Biophys; 1991 May; 286(2):402-8. PubMed ID: 1654789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cleavage of synthetic peptides by purified poliovirus 3C proteinase.
    Pallai PV; Burkhardt F; Skoog M; Schreiner K; Bax P; Cohen KA; Hansen G; Palladino DE; Harris KS; Nicklin MJ
    J Biol Chem; 1989 Jun; 264(17):9738-41. PubMed ID: 2542331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrolysis of a series of synthetic peptide substrates by the human rhinovirus 14 3C proteinase, cloned and expressed in Escherichia coli.
    Orr DC; Long AC; Kay J; Dunn BM; Cameron JM
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2931-42. PubMed ID: 2555433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and purification of recombinant rhinovirus 14 3CD proteinase and its comparison to the 3C proteinase.
    Davis GJ; Wang QM; Cox GA; Johnson RB; Wakulchik M; Dotson CA; Villarreal EC
    Arch Biochem Biophys; 1997 Oct; 346(1):125-30. PubMed ID: 9328292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mengo virus 3C proteinase: recombinant expression, intergenus substrate cleavage and localization in vivo.
    Hall DJ; Palmenberg AC
    Virus Genes; 1996; 13(2):99-110. PubMed ID: 8972564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis A virus 3C proteinase substrate specificity.
    Jewell DA; Swietnicki W; Dunn BM; Malcolm BA
    Biochemistry; 1992 Sep; 31(34):7862-9. PubMed ID: 1510973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple purification and fluorescent assay method of the poliovirus 3C protease searching for specific inhibitors.
    Hata S; Sato T; Sorimachi H; Ishiura S; Suzuki K
    J Virol Methods; 2000 Feb; 84(2):117-26. PubMed ID: 10680961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A consensus sequence for substrate hydrolysis by rhinovirus 3C proteinase.
    Long AC; Orr DC; Cameron JM; Dunn BM; Kay J
    FEBS Lett; 1989 Nov; 258(1):75-8. PubMed ID: 2556299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid method for determination of endoproteinase substrate specificity: specificity of the 3C proteinase from hepatitis A virus.
    Petithory JR; Masiarz FR; Kirsch JF; Santi DV; Malcolm BA
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11510-4. PubMed ID: 1662396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cleavage specificity of purified recombinant hepatitis A virus 3C proteinase on natural substrates.
    Schultheiss T; Sommergruber W; Kusov Y; Gauss-Müller V
    J Virol; 1995 Mar; 69(3):1727-33. PubMed ID: 7853510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Terminomics TAILS Identifies Host Cell Substrates of Poliovirus and Coxsackievirus B3 3C Proteinases That Modulate Virus Infection.
    Jagdeo JM; Dufour A; Klein T; Solis N; Kleifeld O; Kizhakkedathu J; Luo H; Overall CM; Jan E
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29437971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteinase 3C of hepatitis A virus (HAV) cleaves the HAV polyprotein P2-P3 at all sites including VP1/2A and 2A/2B.
    Schultheiss T; Kusov YY; Gauss-Müller V
    Virology; 1994 Jan; 198(1):275-81. PubMed ID: 8259663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poliovirus proteinase 3C: large-scale expression, purification, and specific cleavage activity on natural and synthetic substrates in vitro.
    Nicklin MJ; Harris KS; Pallai PV; Wimmer E
    J Virol; 1988 Dec; 62(12):4586-93. PubMed ID: 2846872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific mutagenesis of cDNA clones expressing a poliovirus proteinase.
    Semler BL; Johnson VH; Dewalt PG; Ypma-Wong MF
    J Cell Biochem; 1987 Jan; 33(1):39-51. PubMed ID: 3029150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the poliovirus 3CD proteinase S1-specificity pocket affect substrate recognition and RNA binding.
    Blair WS; Nguyen JH; Parsley TB; Semler BL
    Virology; 1996 Apr; 218(1):1-13. PubMed ID: 8615011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant poliovirus 3C protease. The enzyme application to protein specific fragmentation.
    Sablina EP; Antonov VK
    FEBS Lett; 1991 Jun; 283(2):291-4. PubMed ID: 1646125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further requirements for cleavage by the murine coronavirus 3C-like proteinase: identification of a cleavage site within ORF1b.
    Piñón JD; Teng H; Weiss SR
    Virology; 1999 Oct; 263(2):471-84. PubMed ID: 10544119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of essential amino acid residues in the functional activity of poliovirus 2A protease.
    Yu SF; Lloyd RE
    Virology; 1991 Jun; 182(2):615-25. PubMed ID: 1850921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of 3C protease from human rhinovirus strain 1B by peptidyl bromomethylketonehydrazides.
    Kati WM; Sham HL; McCall JO; Montgomery DA; Wang GT; Rosenbrook W; Miesbauer L; Buko A; Norbeck DW
    Arch Biochem Biophys; 1999 Feb; 362(2):363-75. PubMed ID: 9989947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage specificity on synthetic peptide substrates of human rhinovirus 2 proteinase 2A.
    Sommergruber W; Ahorn H; Zöphel A; Maurer-Fogy I; Fessl F; Schnorrenberg G; Liebig HD; Blaas D; Kuechler E; Skern T
    J Biol Chem; 1992 Nov; 267(31):22639-44. PubMed ID: 1331062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.